161 related articles for article (PubMed ID: 22814579)
1. Expression and prognostic significance of Src family members in renal clear cell carcinoma.
Qayyum T; McArdle PA; Lamb GW; Jordan F; Orange C; Seywright M; Horgan PG; Jones RJ; Oades G; Aitchison MA; Edwards J
Br J Cancer; 2012 Aug; 107(5):856-63. PubMed ID: 22814579
[TBL] [Abstract][Full Text] [Related]
2. Nuclear expression of Lyn, a Src family kinase member, is associated with poor prognosis in renal cancer patients.
Roseweir AK; Qayyum T; Lim Z; Hammond R; MacDonald AI; Fraser S; Oades GM; Aitchison M; Jones RJ; Edwards J
BMC Cancer; 2016 Mar; 16():229. PubMed ID: 26984511
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer patients' clinical outcome measures are associated with Src kinase family member expression.
Elsberger B; Fullerton R; Zino S; Jordan F; Mitchell TJ; Brunton VG; Mallon EA; Shiels PG; Edwards J
Br J Cancer; 2010 Sep; 103(6):899-909. PubMed ID: 20717116
[TBL] [Abstract][Full Text] [Related]
4. The interrelationships between Src, Cav-1 and RhoGD12 in transitional cell carcinoma of the bladder.
Qayyum T; Fyffe G; Duncan M; McArdle PA; Hilmy M; Orange C; Halbert G; Seywright M; Horgan PG; Underwood MA; Edwards J
Br J Cancer; 2012 Mar; 106(6):1187-95. PubMed ID: 22353809
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-205 inhibits Src-mediated oncogenic pathways in renal cancer.
Majid S; Saini S; Dar AA; Hirata H; Shahryari V; Tanaka Y; Yamamura S; Ueno K; Zaman MS; Singh K; Chang I; Deng G; Dahiya R
Cancer Res; 2011 Apr; 71(7):2611-21. PubMed ID: 21330408
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive Analysis of Prognostic Value and Immune Infiltration of Src Family Kinases in Hepatocellular Carcinoma.
Yao D; Deng Y; Zhang S; Liang L; Zhang L; Weng S; Chen S
Front Biosci (Landmark Ed); 2023 May; 28(5):90. PubMed ID: 37258470
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 Nef selectively activates Src family kinases Hck, Lyn, and c-Src through direct SH3 domain interaction.
Trible RP; Emert-Sedlak L; Smithgall TE
J Biol Chem; 2006 Sep; 281(37):27029-38. PubMed ID: 16849330
[TBL] [Abstract][Full Text] [Related]
8. Deficiency of Fyn protein is prerequisite for apoptosis induced by Src family kinase inhibitors in human mesothelioma cells.
Eguchi R; Kubo S; Takeda H; Ohta T; Tabata C; Ogawa H; Nakano T; Fujimori Y
Carcinogenesis; 2012 May; 33(5):969-75. PubMed ID: 22354875
[TBL] [Abstract][Full Text] [Related]
9. Silencing of lysyl oxidase‑like 2 inhibits the migration, invasion and epithelial‑to‑mesenchymal transition of renal cell carcinoma cells through the Src/FAK signaling pathway.
Hong X; Yu JJ
Int J Oncol; 2019 May; 54(5):1676-1690. PubMed ID: 30816490
[TBL] [Abstract][Full Text] [Related]
10. Src family kinase tyrosine phosphorylates Toll-like receptor 4 to dissociate MyD88 and Mal/Tirap, suppressing LPS-induced inflammatory responses.
Mitchell J; Kim SJ; Seelmann A; Veit B; Shepard B; Im E; Rhee SH
Biochem Pharmacol; 2018 Jan; 147():119-127. PubMed ID: 29175418
[TBL] [Abstract][Full Text] [Related]
11. Lyn modulates Claudin-2 expression and is a therapeutic target for breast cancer liver metastasis.
Tabariès S; Annis MG; Hsu BE; Tam CE; Savage P; Park M; Siegel PM
Oncotarget; 2015 Apr; 6(11):9476-87. PubMed ID: 25823815
[TBL] [Abstract][Full Text] [Related]
12. Src family kinases, HCK and FGR, associate with local inflammation and tumour progression in colorectal cancer.
Roseweir AK; Powell AGMT; Horstman SL; Inthagard J; Park JH; McMillan DC; Horgan PG; Edwards J
Cell Signal; 2019 Apr; 56():15-22. PubMed ID: 30684564
[TBL] [Abstract][Full Text] [Related]
13. FAK and Src expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival.
Theocharis S; Klijanienko J; Giaginis C; Alexandrou P; Patsouris E; Sastre-Garau X
J Cancer Res Clin Oncol; 2012 Aug; 138(8):1369-77. PubMed ID: 22488171
[TBL] [Abstract][Full Text] [Related]
14. Combined expression of the non-receptor protein tyrosine kinases FAK and Src in primary colorectal cancer is associated with tumor recurrence and metastasis formation.
de Heer P; Koudijs MM; van de Velde CJ; Aalbers RI; Tollenaar RA; Putter H; Morreau J; van de Water B; Kuppen PJ
Eur J Surg Oncol; 2008 Nov; 34(11):1253-61. PubMed ID: 18556171
[TBL] [Abstract][Full Text] [Related]
15. The inhibition of SRC family kinase suppresses pancreatic cancer cell proliferation, migration, and invasion.
Je DW; O YM; Ji YG; Cho Y; Lee DH
Pancreas; 2014 Jul; 43(5):768-76. PubMed ID: 24763074
[TBL] [Abstract][Full Text] [Related]
16. Selective Targeting of SH2 Domain-Phosphotyrosine Interactions of Src Family Tyrosine Kinases with Monobodies.
Kükenshöner T; Schmit NE; Bouda E; Sha F; Pojer F; Koide A; Seeliger M; Koide S; Hantschel O
J Mol Biol; 2017 May; 429(9):1364-1380. PubMed ID: 28347651
[TBL] [Abstract][Full Text] [Related]
17. The Src-Family Kinases SRC and BLK Contribute to the CLDN6-Adhesion Signaling.
Ichikawa-Tomikawa N; Sugimoto K; Kashiwagi K; Chiba H
Cells; 2023 Jun; 12(13):. PubMed ID: 37443730
[TBL] [Abstract][Full Text] [Related]
18. Src family kinases are required for integrin but not PDGFR signal transduction.
Klinghoffer RA; Sachsenmaier C; Cooper JA; Soriano P
EMBO J; 1999 May; 18(9):2459-71. PubMed ID: 10228160
[TBL] [Abstract][Full Text] [Related]
19. Src family kinases involved in the differentiation of human preadipocytes.
Feng J; Zhang X; Shan C; Xia J; Zhang Z; Shi H; Leng K; Wu Y; Ji C; Zhong T
Mol Cell Endocrinol; 2021 Aug; 533():111323. PubMed ID: 34000351
[TBL] [Abstract][Full Text] [Related]
20. Src family kinases differentially influence glioma growth and motility.
Lewis-Tuffin LJ; Feathers R; Hari P; Durand N; Li Z; Rodriguez FJ; Bakken K; Carlson B; Schroeder M; Sarkaria JN; Anastasiadis PZ
Mol Oncol; 2015 Nov; 9(9):1783-98. PubMed ID: 26105207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
